In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the recent FDA approvals of Leqembi and Opill, a price transparency and PBM reform package working its way through Congress, and the recent series C funding raise for Octave.   

Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, CMS, DA, Medicare, drug prices, PBM, Alzheimer’s, women’s health, reproductive health, mental health, telemedicine, virtual care 

Source Links: 

• New Federal Decisions Make Alzheimer’s Drug Leqembi Widely Accessible 
• With nonprescription nod for Perrigo's Opill, the age of the over-the-counter birth control pill arrives in the US 
• House committee moves another price transparency, PBM reform package forward 
• Education and the Workforce Committee Passes Landmark Health Care Package 
• Octave nabs $52M, eyes expansion of in-network therapy services to all 50 states in 2024 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector 

M[email protected] 

Ryan Hummel, Executive and Head of Provider Sector 

[email protected]  

Jen Burke, Director 

[email protected]